Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:743-753
Published online before print January 22, 2008, doi: 10.1161/CIRCULATIONAHA.107.699579
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v118,pe86)
Right arrow All Versions of this Article:
117/6/743    most recent
CIRCULATIONAHA.107.699579v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D’Agostino, R. B.
Right arrow Articles by Kannel, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D’Agostino, R. B., Sr
Right arrow Articles by Kannel, W. B.
Related Collections
Right arrow Epidemiology
Right arrow Other diagnostic testing
Right arrow Risk Factors
Right arrow Risk Factors for Stroke
Right arrowRelated Article

(Circulation. 2008;117:743-753.)
© 2008 American Heart Association, Inc.


Epidemiology

General Cardiovascular Risk Profile for Use in Primary Care

The Framingham Heart Study

Ralph B. D’Agostino, Sr, PhD; Ramachandran S. Vasan, MD; Michael J. Pencina, PhD; Philip A. Wolf, MD; Mark Cobain, PhD; Joseph M. Massaro, PhD; William B. Kannel, MD

From Boston University, Department of Mathematics and Statistics (R.B.D., M.J.P.), School of Medicine (R.S.V., P.A.W., W.B.K.), and Department of Biostatistics (J.M.M.), Boston, Mass; Framingham Heart Study, Framingham, Mass (R.B.D., R.S.V., M.J.P., P.A.W., J.M.M., W.B.K.); and Unilever Research, Corporate Biology, Colworth Park, UK (M.C.).

Correspondence to R.B. D’Agostino, PhD, Chairman, Professor of Mathematics/Statistics and Public Health, Boston University, Department of Mathematics and Statistics, 111 Cummington St, Boston, MA 02215.

Received February 27, 2007; accepted November 30, 2007.

Background— Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents.

Methods and Results— We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions ("general CVD" algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P<0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non–laboratory-based predictors.

Conclusions— A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 711-713. [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
P. W.F. Wilson, S. R. Bozeman, T. M. Burton, D. C. Hoaglin, R. Ben-Joseph, and C. L. Pashos
Prediction of First Events of Coronary Heart Disease and Stroke With Consideration of Adiposity
Circulation, July 8, 2008; 118(2): 124 - 130.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Hippisley-Cox, C. Coupland, Y. Vinogradova, J. Robson, R. Minhas, A. Sheikh, and P. Brindle
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
BMJ, June 28, 2008; 336(7659): 1475 - 1482.
[Abstract] [Full Text] [PDF]